| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2002 | CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | CA2426774A1 Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
| 05/02/2002 | CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | CA2426744A1 Method for in vivo identification of intracellular epitopes |
| 05/02/2002 | CA2426742A1 Haemophilus influenzae basb210 polypeptides and encoding polynucleotides and uses thereof |
| 05/02/2002 | CA2426647A1 Expression vectors and uses thereof |
| 05/02/2002 | CA2426465A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | CA2426463A1 Novel aggrecanase molecules |
| 05/02/2002 | CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | CA2426321A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | CA2425904A1 Materials and methods relating to nucleic acid amplification and profiling |
| 05/02/2002 | CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | CA2425596A1 Methods of therapy for hiv infection |
| 05/02/2002 | CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | CA2421679A1 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/01/2002 | CN1347501A Method of diagnosing transmissible spongiform encephalopathies |
| 05/01/2002 | CN1347460A Monolayer and electrode for detecting label-bearing target and method of use thereof |
| 05/01/2002 | CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
| 05/01/2002 | CN1347457A 植物转化方法 Plant Transformation Methods |
| 05/01/2002 | CN1347456A Collagen-binding physiologically active polypeptide |
| 05/01/2002 | CN1347455A Novel meannose isomerase and DNA encoding enzyme |
| 05/01/2002 | CN1347454A Method for improving agronomic and nutritional value of plants |
| 05/01/2002 | CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| 05/01/2002 | CN1347452A Alpha-agarase and process for producing same |
| 05/01/2002 | CN1347451A Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 05/01/2002 | CN1347449A 芽孢杆菌蛋白生产细胞 Bacillus cell protein production |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 05/01/2002 | CN1347329A Method for producing probe arrays for biological materials using fine particles |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1347283A eNOS mutations useful for gene therapy and therapeutic screening |
| 05/01/2002 | CN1346890A Process for preparing T vector |
| 05/01/2002 | CN1346889A Method for generating active isdime AMV-RT in procaryotic cell |
| 05/01/2002 | CN1346888A Method for producing transgene non-human mammal |
| 05/01/2002 | CN1346887A Production and transport of protein |
| 05/01/2002 | CN1346885A Bacteria and method for producing L-glutamic acid, L-proline or L-arginine |
| 05/01/2002 | CN1083884C Two kinds of encoding insecticidal protein gene and bivalent fused expression vector and their application |
| 05/01/2002 | CN1083850C Microcapsule-type curing agent and thermosetting resin composition |
| 05/01/2002 | CA2327172A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 04/30/2002 | US6380465 Cytochrome P450 enzymes and related compounds and methods |
| 04/30/2002 | US6380464 Plant flavonol synthase homologs |
| 04/30/2002 | US6380463 Gene expression cassette |
| 04/30/2002 | US6380462 Method for increasing stearate content in soybean oil |
| 04/30/2002 | US6380461 Production of pathogen resistant plants |
| 04/30/2002 | US6380460 Insertion tolerance gene into plant; genetic engineering |
| 04/30/2002 | US6380459 Compositions and methods for the modification of gene expression |
| 04/30/2002 | US6380458 Genetic engineering; forming hybrids |
| 04/30/2002 | US6380376 Purity polypeptides |
| 04/30/2002 | US6380375 DNA encoding monkey gonadotropin releasing hormone receptor |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380373 Isolated nucleic acid |
| 04/30/2002 | US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase |
| 04/30/2002 | US6380363 Antibodies to the Ob receptor |
| 04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
| 04/30/2002 | US6380355 Process for obtaining insulin precursors having correctly bonded cystine bridges |
| 04/30/2002 | US6380171 Administering antisense nucleic acid having a nucleotide sequence to suppress expression of pro-protein converting enzyme 5 (pc5) gene or to inhibit pc5 activity for reducing restenosis occuring at injured vascular site |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380169 Metal complex containing oligonucleoside cleavage compounds and therapies |
| 04/30/2002 | US6380160 Gp130 lacking the transmembrane domain |
| 04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
| 04/30/2002 | US6380154 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/30/2002 | US6379968 A method for creating transgenic plants expressing exogenous glucose pyrophosphorylase in the starch producing plastids |
| 04/30/2002 | US6379967 A mutant viral gene that prevents viral replication in human cells; gene therapy |
| 04/30/2002 | US6379965 Nucleic acid noncovalently associated with a polyamine compound that is covalently attached to an endosome disrupting agent such as cholic acid; nonviral vectors |
| 04/30/2002 | US6379964 Forming a protoplasts population of different cells, fusing the protoplast and forming hybrids that are then incubated to promote cell regeneration; regenerated cells are then screened based on desired properties |
| 04/30/2002 | US6379960 A nucleic acid molecule; diagnosis and therapy for breast cancer, hepatitis and alzheimer's disease |
| 04/30/2002 | US6379954 Amido and peptido modified catalytic oligonucleotides |
| 04/30/2002 | US6379950 Recombinant, active caspases and uses thereof |
| 04/30/2002 | US6379945 Gene switch |
| 04/30/2002 | US6379944 A recombinant cell that is permissive for replication of a bovine adenovirus vector; for preparing viable recombinant virus vaccines; gene therapy |
| 04/30/2002 | US6379943 A method where homologous recombination in plasmids is by site specific recombination via cre recombinase, to join two noninfectious dnas to form an infectious dna molecule |
| 04/30/2002 | US6379942 Chemically modified enzymes with multiple charged variants |
| 04/30/2002 | US6379938 Epoxide hydrolase |
| 04/30/2002 | US6379934 Process for the fermentative preparation of L-amino acids using coryneform bacteria |
| 04/30/2002 | US6379933 Method of transferring at least two saccharide units with a polyglycosyltransferase |
| 04/30/2002 | US6379932 Amplifying rna by hydridizing and extending with a first primer to form cdna strand; then hybridize/amplify cdna with second primer; then amplifying second cdna with a third primer comprising of the first amplified sequence |
| 04/30/2002 | US6379931 Derived from spacer reagent 3-(4,4'-dimethoxytrityloxy)propane-1-((2-cyanoethyl)-(n,n-diisopropyl)) -phosphoramidite; use treating viral and rna-mediated diseases such as hiv |
| 04/30/2002 | US6379930 Reagents necessary to perform nucleic acid amplification are encapsulated in liposome vesicles; prevents undesirable side reactions |
| 04/30/2002 | US6379928 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
| 04/30/2002 | US6379927 Retinoblastoma fusion proteins |
| 04/30/2002 | US6379926 Polynucleotides encoding chemokine β-6 antagonists |
| 04/30/2002 | US6379924 Amplifying protein products by using fungal cells having a plasmid with a funcional coding sequence and also having a modified level of ubiquitin conjugating enzymes activity; then culturing the cell to produce a fungal derived product |
| 04/30/2002 | US6379923 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/30/2002 | US6379912 Motor proteins and method for their use |
| 04/30/2002 | US6379907 Detecting cancerous cervical lesions from atypical glandular cells of undetermined significance papanicolaou smear cells based on the presence of a specific antigen not found in atypical cells, but present on normal endocervical cells |
| 04/30/2002 | US6379903 Purification of recombinant proteins fused to multiple epitopes |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379897 Methods for gene expression monitoring on electronic microarrays |
| 04/30/2002 | US6379894 Method for screening compounds capable of inhibiting binding between the transcription factor of STAT1 and the transcription factor of USF1 |
| 04/30/2002 | US6379890 Method for determining asthma susceptibility |
| 04/30/2002 | US6379888 A method using a signal primer that is partially single and double stranded; in the presence of a target, strand displacement occurs causing a conformational change in a reporter probe and quenches the fluorecent signal |
| 04/30/2002 | US6379887 A polynucleotide; used in cosmetic and dermatology development |
| 04/30/2002 | US6379881 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379698 Fusogenic lipids and vesicles |
| 04/30/2002 | US6379675 Immunological combination compositions and methods |
| 04/30/2002 | US6379674 Use of herpes vectors for tumor therapy |
| 04/30/2002 | US6379671 Using a polypeptide antigen mixture |